首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   391篇
  免费   5篇
  国内免费   3篇
耳鼻咽喉   1篇
儿科学   10篇
妇产科学   3篇
基础医学   93篇
口腔科学   3篇
临床医学   34篇
内科学   38篇
皮肤病学   7篇
神经病学   10篇
特种医学   26篇
外科学   85篇
综合类   6篇
一般理论   1篇
预防医学   34篇
眼科学   1篇
药学   36篇
中国医学   1篇
肿瘤学   10篇
  2022年   6篇
  2021年   4篇
  2019年   4篇
  2018年   5篇
  2016年   4篇
  2014年   3篇
  2013年   5篇
  2012年   6篇
  2011年   12篇
  2010年   3篇
  2009年   6篇
  2008年   9篇
  2007年   12篇
  2006年   8篇
  2005年   6篇
  2004年   11篇
  2003年   14篇
  2002年   7篇
  2001年   9篇
  2000年   11篇
  1999年   6篇
  1998年   9篇
  1997年   4篇
  1995年   3篇
  1994年   4篇
  1992年   9篇
  1991年   14篇
  1990年   7篇
  1989年   15篇
  1988年   14篇
  1987年   14篇
  1986年   12篇
  1985年   15篇
  1984年   9篇
  1983年   9篇
  1982年   7篇
  1980年   5篇
  1979年   5篇
  1978年   5篇
  1977年   5篇
  1975年   10篇
  1974年   5篇
  1973年   15篇
  1972年   7篇
  1971年   5篇
  1970年   4篇
  1969年   6篇
  1968年   5篇
  1967年   5篇
  1965年   5篇
排序方式: 共有399条查询结果,搜索用时 15 毫秒
61.
Sahud M  Zhukov O  Mo K  Popov J  Dlott J 《Haemophilia》2012,18(5):777-781
Summary. The evaluation of a prolonged aPTT often includes Lupus Anticoagulant, Antiphospholipid Antibodies, and Factor VIII (FVIII) inhibitors. We have noticed that patient samples positive for lupus antibody (LA) are frequently also positive for FVIII IgG antibodies in an enzyme‐linked immunosorbent assay (ELISA), indicating the need for follow‐up testing with a more labour‐intensive functional assay for FVIII inhibition. This study evaluates the potential for a FVIII IgG ELISA to yield false‐positive results in patient samples positive for LA or other antiphospholipid antibodies. A total of 289 residual de‐identified patient samples positive for LA (n = 143), anti‐cardiolipin IgG (n = 84), or beta2‐glycoprotein antibody (n = 62) were tested for FVIII IgG using a commercial ELISA. Samples with positive FVIII IgG ELISA results were further tested for FVIII activity using a clot‐based FVIII inhibitor assay. The FVIII IgG ELISA yielded positive results in 39 (13%) of the samples tested, including 13/143 (13%) LA‐positive, 15/85 (18%) aCL IgG‐positive and 6/62 (10%) β2‐glycoprotein IgG‐positive samples. The clot‐based FVIII inhibitor assay yielded negative results in all 39 FVIII IgG‐positive specimens tested, indicating discrepancy with the FVIII IgG ELISA results. Patient specimens positive for LA, aCL IgG, or β2‐glycoprotein IgG may yield false‐positive results for FVIII antibodies. Caution is warranted in interpreting FVIII antibody results in these cases.  相似文献   
62.
AIM:To study the relationship between N-ras gene mutation and p53 gene expression in the carcinogenesis and the development of human hepatocellular carcinomas (HCC).METHODS:The N-ras gene mutation and the p53 gene expression were analyzed in 29 cases of HCC by polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) and immunohistochemistry.RESULTS:Thirteen cases of HCCs were p53 positive (44.8%), which showed a rather high Cpercen-tage of p53 gene mutation in Guangxi. The aberrations at N-ras codon 2-37 were found in 79.31% of HCCs and 80.77% of adjacent non-tumorous liver tissues. More than 2 point mutations of N-ras gene were observed in 22 cases (75.86%). Twelve cases (41.37%) of HCCs showed both N-ras gene mutation and p53 gene expression.CONCLUSION:N-ras gene and p53 gene may be involved in the carcinogenesis and the development of HCC.That 38% of HCCs with N-ras gene mutation did not express p53 protein indicates that some other genes or factors may participate in the carcinogenesis and the development of HCC.  相似文献   
63.
Translated from Khimiko-farmatsevticheskii Zhurnal, Vol. 23, No. 6, pp. 684–686, June, 1989.  相似文献   
64.
65.
66.
67.
The data are provided on the immune status in 108 patients with chronic pancreatitis. The authors revealed the immune responses toward pancreatic tissue, deoxyribonucleic acid and deoxyribonuclease. Based on the revealed autoimmune responses to the pancreatic tissue, two patterns of chronic pancreatitis were distinguished: the immunopositive and immunonegative. It is suggested that immunologic mechanisms are involved into the pathogenesis of the immunopositive pattern of chronic pancreatitis.  相似文献   
68.
The hemostatic properties of ozone were studied on models of parenchymatous (from a wound in the liver) and stem (from the stump of the tail) bleedings in rats. An air-ozone mixture at a flow rate of 1 liter/min and a concentration of 2 mg/ml was found to exert a pronounced hemostatic effect. Our findings indicate that the arrest of bleeding under the influence of ozone is due to the formation of a fibrin membrane on the surface of the flowing blood, this leading to rapid and effective hemostasis. Preliminary drying of the wound still further speeds the onset of hemostasis. Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 120 N o 7 pp. 62–65, July, 1995 Presented by D. S. Sarkisov, Member of the Russian Academy of Medical Sciences  相似文献   
69.
To understand the role of dopamine in the mediation of opiate's analgesic and reinforcing activity, the influence of pharmacologically-induced increase (apomorphine in a high dose) and decrease (haloperidol and apomorphine in a low "presynaptic" dose) of dopamine neurotransmission on morphine-induced depression of vocalization and movement reactivity was investigated in freely behaving rats. Strong enhancement of morphine-induced vocalization reactivity depression and a weakening of movement reactivity depression typical to concomitant pharmacological increase of dopamine neurotransmission may represent the enhancement of its reinforcing and analgesic properties and inhibition of its depressive/sedative activity. Enhancement of MOR-induced depression of movement and vocalization reactivity characteristic of drug-induced decrease of dopamine neurotransmission may be the consequence of the blockade of opiate's reinforcing and stimulatory activity and summation of depressive/sedative actions typical to these drugs administered alone.  相似文献   
70.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号